Exact Mass: 437.15081520000007

Exact Mass Matches: 437.15081520000007

Found 20 metabolites which its exact mass value is equals to given mass value 437.15081520000007, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride

7-(1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoranyl-8-methoxy-4-oxidanylidene-quinoline-3-carboxylic acid hydrochloride

C21H25ClFN3O4 (437.15175320000003)


   

Moxifloxacin hydrochloride

Moxifloxacin hydrochloride

C21H25ClFN3O4 (437.15175320000003)


   

Cys Cys Gly Arg

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Cys Arg Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Cys Gly Cys Arg

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Gly Arg Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Cys Arg Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Cys Arg Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Nalbuphine-6-sulfate

Nalbuphine-6-sulfate

C21H27NO7S (437.15081520000007)


   

Nalbuphine-3-sulfate

Nalbuphine-3-sulfate

C21H27NO7S (437.15081520000007)


   

Gly Cys Cys Arg

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C14H27N7O5S2 (437.1515012)


   

Gly Cys Arg Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Gly Arg Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Arg Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C14H27N7O5S2 (437.1515012)


   

Arg Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Arg Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N7O5S2 (437.1515012)


   

Moxifloxacin HCl

Moxifloxacin hydrochloride

C21H25ClFN3O4 (437.15175320000003)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-

3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-

C21H25ClFN3O4 (437.15175320000003)


   

asterriquinone C1(1-)

asterriquinone C1(1-)

C27H21N2O4- (437.1501246)


   

ST 19:5;O4;Tau

ST 19:5;O4;Tau

C21H27NO7S (437.15081520000007)